{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T20:25:31Z","timestamp":1793823931358,"version":"4.6.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,5,27]],"date-time":"2021-05-27T00:00:00Z","timestamp":1622073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,27]],"date-time":"2021-05-27T00:00:00Z","timestamp":1622073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R43HL142396"],"award-info":[{"award-number":["R43HL142396"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R43HL142396"],"award-info":[{"award-number":["R43HL142396"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R35HL150797"],"award-info":[{"award-number":["R35HL150797"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["RO1HL125356"],"award-info":[{"award-number":["RO1HL125356"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["RO1HL080264"],"award-info":[{"award-number":["RO1HL080264"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["RO1HL062350"],"award-info":[{"award-number":["RO1HL062350"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HHSN268201400007C"],"award-info":[{"award-number":["HHSN268201400007C"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HHSN268201700002C"],"award-info":[{"award-number":["HHSN268201700002C"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute"},{"name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute"},{"name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute"},{"name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute"},{"name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute"},{"name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute"},{"name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Systemic inflammation as manifested in sepsis is an excessive, life-threatening inflammatory response to severe bacterial or viral infection or extensive injury. It is also a thrombo-inflammatory condition associated with vascular leakage\/hemorrhage and thrombosis that is not effectively treated by current anti-inflammatory or anti-thrombotic drugs. Here, we show that MB2mP6 peptide nanoparticles, targeting the G\u03b1<jats:sub>13<\/jats:sub>-mediated integrin \u201coutside-in\u201d signaling in leukocytes and platelets, inhibited both inflammation and thrombosis without causing hemorrhage\/vascular leakage. MB2mP6 improved mouse survival when infused immediately or hours after onset of severe sepsis. Furthermore, platelet G\u03b1<jats:sub>13<\/jats:sub> knockout inhibited septic thrombosis whereas leukocyte G\u03b1<jats:sub>13<\/jats:sub> knockout diminished septic inflammation, each moderately improving survival. Dual platelet\/leukocyte G\u03b1<jats:sub>13<\/jats:sub> knockout inhibited septic thrombosis and inflammation, further improving survival similar to MB2mP6. These results demonstrate that inflammation and thrombosis independently contribute to poor outcomes and exacerbate each other in systemic inflammation, and reveal a concept of dual anti-inflammatory\/anti-thrombotic therapy without exacerbating vascular leakage.<\/jats:p>","DOI":"10.1038\/s41467-021-23409-0","type":"journal-article","created":{"date-parts":[[2021,5,27]],"date-time":"2021-05-27T10:12:23Z","timestamp":1622110343000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Targeting G\u03b113-integrin interaction ameliorates systemic inflammation"],"prefix":"10.1038","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9013-690X","authenticated-orcid":false,"given":"Ni","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0205-8807","authenticated-orcid":false,"given":"Yaping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Keegan","family":"Delaney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2665-0269","authenticated-orcid":false,"given":"Can","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8365-8451","authenticated-orcid":false,"given":"Yanyan","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randal A.","family":"Skidgel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9842-8192","authenticated-orcid":false,"given":"Xiaoping","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,27]]},"reference":[{"key":"23409_CR1","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1056\/NEJMra1208623","volume":"369","author":"DC Angus","year":"2013","unstructured":"Angus, D. C. & van der Poll, T. Severe sepsis and septic shock. N. Engl. J. Med. 369, 840\u2013851 (2013).","journal-title":"N. Engl. J. Med."},{"key":"23409_CR2","doi-asserted-by":"publisher","first-page":"S26","DOI":"10.1097\/CCM.0b013e3181c98d21","volume":"38","author":"M Levi","year":"2010","unstructured":"Levi, M. & van der Poll, T. Inflammation and coagulation. Crit. Care Med. 38, S26\u2013S34 (2010).","journal-title":"Crit. Care Med."},{"key":"23409_CR3","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.maturitas.2008.11.008","volume":"61","author":"CT Esmon","year":"2008","unstructured":"Esmon, C. T. Crosstalk between inflammation and thrombosis. Maturitas 61, 122\u2013131 (2008).","journal-title":"Maturitas"},{"key":"23409_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/cti.2016.39","volume":"5","author":"RP Davis","year":"2016","unstructured":"Davis, R. P., Miller-Dorey, S. & Jenne, C. N. Platelets and coagulation in infection. Clin. Trans. Immunol. 5, e89 (2016).","journal-title":"Clin. Trans. Immunol."},{"key":"23409_CR5","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1001\/jama.2019.20153","volume":"323","author":"JM Sanders","year":"2020","unstructured":"Sanders, J. M., Monogue, M. L., Jodlowski, T. Z. & Cutrell, J. B. Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a review. JAMA 323, 1824\u20131836 (2020).","journal-title":"JAMA"},{"key":"23409_CR6","doi-asserted-by":"publisher","first-page":"173644","DOI":"10.1016\/j.ejphar.2020.173644","volume":"889","author":"C Stasi","year":"2020","unstructured":"Stasi, C., Fallani, S., Voller, F. & Silvestri, C. Treatment for COVID-19: an overview. Eur. J. Pharm. 889, 173644 (2020).","journal-title":"Eur. J. Pharm."},{"key":"23409_CR7","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/nrd4368","volume":"13","author":"MP Fink","year":"2014","unstructured":"Fink, M. P. & Warren, H. S. Strategies to improve drug development for sepsis. Nat. Rev. Drug Discov. 13, 741\u2013758 (2014).","journal-title":"Nat. Rev. Drug Discov."},{"key":"23409_CR8","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1056\/NEJM200103083441001","volume":"344","author":"GR Bernard","year":"2001","unstructured":"Bernard, G. R. et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N. Engl. J. Med. 344, 699\u2013709 (2001).","journal-title":"N. Engl. J. Med."},{"key":"23409_CR9","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1111\/j.1365-2141.2009.08020.x","volume":"148","author":"PP Sarangi","year":"2010","unstructured":"Sarangi, P. P., Lee, H. W. & Kim, M. Activated protein C action in inflammation. Br. J. Haematol. 148, 817\u2013833 (2010).","journal-title":"Br. J. Haematol."},{"key":"23409_CR10","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s00281-011-0284-6","volume":"34","author":"CT Esmon","year":"2012","unstructured":"Esmon, C. T. Protein C anticoagulant system\u2013anti-inflammatory effects. Semin Immunopathol. 34, 127\u2013132 (2012).","journal-title":"Semin Immunopathol."},{"key":"23409_CR11","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1056\/NEJMsb020574","volume":"347","author":"HS Warren","year":"2002","unstructured":"Warren, H. S., Suffredini, A. F., Eichacker, P. Q. & Munford, R. S. Risks and benefits of activated protein C treatment for severe sepsis. N. Engl. J. Med. 347, 1027\u20131030 (2002).","journal-title":"N. Engl. J. Med."},{"key":"23409_CR12","first-page":"CD004388","volume":"12","author":"AJ Marti-Carvajal","year":"2012","unstructured":"Marti-Carvajal, A. J., Sola, I., Gluud, C., Lathyris, D. & Cardona, A. F. Human recombinant protein C for severe sepsis and septic shock in adult and paediatric patients. Cochrane Database Syst. Rev. 12, CD004388 (2012).","journal-title":"Cochrane Database Syst. Rev."},{"key":"23409_CR13","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2174\/157488612800492735","volume":"7","author":"RJ Benefield","year":"2012","unstructured":"Benefield, R. J., Drevets, D. A., Huycke, M. M. & Gentry, C. A. A multicenter evaluation of the safety of drotrecogin alfa (activated) in patients with baseline bleeding precautions. Curr. Drug Saf. 7, 3\u20137 (2012).","journal-title":"Curr. Drug Saf."},{"key":"23409_CR14","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1097\/CCM.0b013e3181b4275c","volume":"38","author":"J Winning","year":"2010","unstructured":"Winning, J. et al. Antiplatelet drugs and outcome in mixed admissions to an intensive care unit. Crit. Care Med. 38, 32\u201337 (2010).","journal-title":"Crit. Care Med."},{"key":"23409_CR15","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1111\/j.1538-7836.2009.03352.x","volume":"7","author":"M Seidel","year":"2009","unstructured":"Seidel, M., Winning, J., Claus, R. A., Bauer, M. & Losche, W. Beneficial effect of clopidogrel in a mouse model of polymicrobial sepsis. J. Thromb. Haemost. 7, 1030\u20131032 (2009).","journal-title":"J. Thromb. Haemost."},{"key":"23409_CR16","doi-asserted-by":"publisher","first-page":"517","DOI":"10.3109\/09537104.2013.842965","volume":"25","author":"RF Storey","year":"2014","unstructured":"Storey, R. F. et al. Lower mortality following pulmonary adverse events and sepsis with ticagrelor compared to clopidogrel in the PLATO study. Platelets 25, 517\u2013525 (2014).","journal-title":"Platelets"},{"key":"23409_CR17","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1161\/ATVBAHA.116.307401","volume":"36","author":"E Liverani","year":"2016","unstructured":"Liverani, E., Rico, M. C., Tsygankov, A. Y., Kilpatrick, L. E. & Kunapuli, S. P. P2Y12 Receptor modulates sepsis-induced inflammation. Arterioscler. Thromb. Vasc. Biol. 36, 961\u2013971 (2016).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"23409_CR18","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1007\/s00134-015-3760-y","volume":"41","author":"MJ Tsai","year":"2015","unstructured":"Tsai, M. J. et al. Association of prior antiplatelet agents with mortality in sepsis patients: a nationwide population-based cohort study. Intensive Care Med. 41, 806\u2013813 (2015).","journal-title":"Intensive Care Med."},{"key":"23409_CR19","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1007\/s00134-016-4230-x","volume":"42","author":"MJ Tsai","year":"2016","unstructured":"Tsai, M. J., Shih, C. J. & Chen, Y. T. Association of prior antiplatelet agents with mortality in sepsis patients. Intensive Care Med. 42, 605\u2013607 (2016).","journal-title":"Intensive Care Med."},{"key":"23409_CR20","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1055\/s-0037-1616241","volume":"86","author":"BS Coller","year":"2001","unstructured":"Coller, B. S. Anti-GPIIb\/IIIa drugs: current strategies and future directions. Thromb. Haemost. 86, 427\u2013443 (2001).","journal-title":"Thromb. Haemost."},{"key":"23409_CR21","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1161\/ATVBAHA.114.303411","volume":"35","author":"B Estevez","year":"2015","unstructured":"Estevez, B., Shen, B. & Du, X. Targeting integrin and integrin signaling in treating thrombosis. Arterioscler. Thromb. Vasc. Biol. 35, 24\u201329 (2015).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"23409_CR22","doi-asserted-by":"crossref","unstructured":"Springer, T. A., Thompson, W. S., Miller, L. J., Schmalstieg, F. C. & Anderson, D. C. Inherited deficiency of the Mac-1, LFA-1, 150,95 glycoprotein family and its molecular basis. J. Exp. Med. 160, 1901\u20131918 (1984).","DOI":"10.1084\/jem.160.6.1901"},{"key":"23409_CR23","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/nature12613","volume":"503","author":"B Shen","year":"2013","unstructured":"Shen, B. et al. A directional switch of integrin signalling and a new anti-thrombotic strategy. Nature 503, 131\u2013135 (2013).","journal-title":"Nature"},{"key":"23409_CR24","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1126\/science.1174779","volume":"327","author":"H Gong","year":"2010","unstructured":"Gong, H. et al. G protein subunit Galpha13 binds to integrin alphaIIbbeta3 and mediates integrin \u201coutside-in\u201d signaling. Science 327, 340\u2013343 (2010).","journal-title":"Science"},{"key":"23409_CR25","doi-asserted-by":"crossref","unstructured":"Pang, A. et al. High-loading G\u03b113-binding EXE peptide nanoparticles prevent thrombosis and protect mice from cardiac ischemia\/reperfusion injury. Sci. Transl. Med. 12, eaaz7287 (2020).","DOI":"10.1126\/scitranslmed.aaz7287"},{"key":"23409_CR26","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/nrd.2015.10","volume":"15","author":"K Ley","year":"2016","unstructured":"Ley, K., Rivera-Nieves, J., Sandborn, W. J. & Shattil, S. Integrin-based therapeutics: biological basis, clinical use and new drugs. Nat. Rev. Drug Discov. 15, 173\u2013183 (2016).","journal-title":"Nat. Rev. Drug Discov."},{"key":"23409_CR27","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/BF02041244","volume":"47","author":"J Auwerx","year":"1991","unstructured":"Auwerx, J. The human leukemia cell line, THP-1: a multifacetted model for the study of monocyte-macrophage differentiation. Experientia 47, 22\u201331 (1991).","journal-title":"Experientia"},{"key":"23409_CR28","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1055\/s-0033-1343894","volume":"39","author":"M Levi","year":"2013","unstructured":"Levi, M., Schultz, M. & van der Poll, T. Sepsis and thrombosis. Semin Thromb. Hemost. 39, 559\u2013566 (2013).","journal-title":"Semin Thromb. Hemost."},{"key":"23409_CR29","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.thromres.2011.10.013","volume":"129","author":"N Semeraro","year":"2012","unstructured":"Semeraro, N., Ammollo, C. T., Semeraro, F. & Colucci, M. Sepsis, thrombosis and organ dysfunction. Thromb. Res. 129, 290\u2013295 (2012).","journal-title":"Thromb. Res."},{"key":"23409_CR30","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1038\/nm943","volume":"9","author":"A Moers","year":"2003","unstructured":"Moers, A. et al. G13 is an essential mediator of platelet activation in hemostasis and thrombosis. Nat. Med. 9, 1418\u20131422 (2003).","journal-title":"Nat. Med."},{"key":"23409_CR31","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1126\/science.280.5372.2109","volume":"280","author":"T Kozasa","year":"1998","unstructured":"Kozasa, T. et al. p115 RhoGEF, a GTPase activating protein for Galpha12 and Galpha13. Science 280, 2109\u20132111 (1998).","journal-title":"Science"},{"key":"23409_CR32","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1016\/j.cellsig.2007.03.004","volume":"19","author":"B Kreutz","year":"2007","unstructured":"Kreutz, B., Hajicek, N., Yau, D. M., Nakamura, S. & Kozasa, T. Distinct regions of Galpha13 participate in its regulatory interactions with RGS homology domain-containing RhoGEFs. Cell Signal 19, 1681\u20131689 (2007).","journal-title":"Cell Signal"},{"key":"23409_CR33","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1124\/mol.115.097857","volume":"88","author":"OM Yu","year":"2015","unstructured":"Yu, O. M. & Brown, J. H. G Protein-coupled receptor and RhoA-stimulated transcriptional responses: links to inflammation, differentiation, and cell proliferation. Mol. Pharm. 88, 171\u2013180 (2015).","journal-title":"Mol. Pharm."},{"key":"23409_CR34","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12929-017-0370-8","volume":"24","author":"S Seemann","year":"2017","unstructured":"Seemann, S., Zohles, F. & Lupp, A. Comprehensive comparison of three different animal models for systemic inflammation. J. Biomed. Sci. 24, 60 (2017).","journal-title":"J. Biomed. Sci."},{"key":"23409_CR35","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1016\/S0002-9440(10)63268-3","volume":"165","author":"CL Speyer","year":"2004","unstructured":"Speyer, C. L. et al. Novel chemokine responsiveness and mobilization of neutrophils during sepsis. Am. J. Pathol. 165, 2187\u20132196 (2004).","journal-title":"Am. J. Pathol."},{"key":"23409_CR36","doi-asserted-by":"publisher","first-page":"e79037","DOI":"10.1371\/journal.pone.0079037","volume":"8","author":"R Bhargava","year":"2013","unstructured":"Bhargava, R. et al. Acute lung injury and acute kidney injury are established by four hours in experimental sepsis and are improved with pre, but not post, sepsis administration of TNF-alpha antibodies. PLoS ONE 8, e79037 (2013).","journal-title":"PLoS ONE"},{"key":"23409_CR37","doi-asserted-by":"publisher","first-page":"e88501","DOI":"10.1371\/journal.pone.0088501","volume":"9","author":"SE Gill","year":"2014","unstructured":"Gill, S. E., Taneja, R., Rohan, M., Wang, L. & Mehta, S. Pulmonary microvascular albumin leak is associated with endothelial cell death in murine sepsis-induced lung injury in vivo. PLoS ONE 9, e88501 (2014).","journal-title":"PLoS ONE"},{"key":"23409_CR38","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1080\/10739680500466343","volume":"13","author":"G Singer","year":"2006","unstructured":"Singer, G., Urakami, H., Specian, R. D., Stokes, K. Y. & Granger, D. N. Platelet recruitment in the murine hepatic microvasculature during experimental sepsis: role of neutrophils. Microcirculation 13, 89\u201397 (2006).","journal-title":"Microcirculation"},{"key":"23409_CR39","doi-asserted-by":"publisher","first-page":"464","DOI":"10.2174\/1389201011314040012","volume":"14","author":"AA Banerjee","year":"2013","unstructured":"Banerjee, A. A. et al. Enhanced oral bioavailability of the hydrophobic chemopreventive agent (Sr13668) in beagle dogs. Curr. Pharm. Biotechnol. 14, 464\u2013469 (2013).","journal-title":"Curr. Pharm. Biotechnol."},{"key":"23409_CR40","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jim.2016.01.012","volume":"430","author":"ME Lund","year":"2016","unstructured":"Lund, M. E., To, J., O\u2019Brien, B. A. & Donnelly, S. The choice of phorbol 12-myristate 13-acetate differentiation protocol influences the response of THP-1 macrophages to a pro-inflammatory stimulus. J. Immunol. Methods 430, 64\u201370 (2016).","journal-title":"J. Immunol. Methods"},{"key":"23409_CR41","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1083\/jcb.124.4.619","volume":"124","author":"SM Frisch","year":"1994","unstructured":"Frisch, S. M. & Francis, H. Disruption of epithelial cell-matrix interactions induces apoptosis. J. Cell Biol. 124, 619\u2013626 (1994).","journal-title":"J. Cell Biol."},{"key":"23409_CR42","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/273345a0","volume":"273","author":"J Folkman","year":"1978","unstructured":"Folkman, J. & Moscona, A. Role of cell shape in growth control. Nature 273, 345\u2013349 (1978).","journal-title":"Nature"},{"key":"23409_CR43","doi-asserted-by":"publisher","first-page":"3658","DOI":"10.1091\/mbc.E15-05-0274","volume":"26","author":"B Shen","year":"2015","unstructured":"Shen, B. et al. The interaction of Galpha13 with integrin beta1 mediates cell migration by dynamic regulation of RhoA. Mol. Biol. Cell 26, 3658\u20133670 (2015).","journal-title":"Mol. Biol. Cell"},{"key":"23409_CR44","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/978-1-62703-481-4_3","volume":"1031","author":"BK Davis","year":"2013","unstructured":"Davis, B. K. Isolation, culture, and functional evaluation of bone marrow-derived macrophages. Methods Mol. Biol. 1031, 27\u201335 (2013).","journal-title":"Methods Mol. Biol."},{"key":"23409_CR45","doi-asserted-by":"crossref","unstructured":"Feoktistova, M., Geserick, P. & Leverkus, M. Crystal violet assay for determining viability of cultured cells. Cold Spring Harb. Protoc. 2016, pdb prot087379 (2016).","DOI":"10.1101\/pdb.prot087379"},{"key":"23409_CR46","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1161\/ATVBAHA.113.302339","volume":"33","author":"H Yin","year":"2013","unstructured":"Yin, H. et al. Role for platelet glycoprotein Ib-IX and effects of its inhibition in endotoxemia-induced thrombosis, thrombocytopenia, and mortality. Arterioscler. Thromb. Vasc. Biol. 33, 2529\u20132537 (2013).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"23409_CR47","doi-asserted-by":"publisher","first-page":"4586","DOI":"10.1182\/blood-2012-12-470765","volume":"121","author":"B Estevez","year":"2013","unstructured":"Estevez, B. et al. LIM kinase-1 selectively promotes glycoprotein Ib-IX-mediated TXA2 synthesis, platelet activation, and thrombosis. Blood 121, 4586\u20134594 (2013).","journal-title":"Blood"},{"key":"23409_CR48","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1182\/blood-2008-02-140970","volume":"112","author":"H Yin","year":"2008","unstructured":"Yin, H. et al. Src family tyrosine kinase Lyn mediates VWF\/GPIb-IX-induced platelet activation via the cGMP signaling pathway. Blood 112, 1139\u20131146 (2008).","journal-title":"Blood"},{"key":"23409_CR49","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/978-1-0716-0154-9_10","volume":"2087","author":"A Smirnov","year":"2020","unstructured":"Smirnov, A., Solga, M. D., Lannigan, J. & Criss, A. K. Using imaging flow cytometry to quantify neutrophil phagocytosis. Methods Mol. Biol. 2087, 127\u2013140 (2020).","journal-title":"Methods Mol. Biol."},{"key":"23409_CR50","doi-asserted-by":"publisher","first-page":"7720","DOI":"10.4049\/jimmunol.179.11.7720","volume":"179","author":"N Cheng","year":"2007","unstructured":"Cheng, N., He, R., Tian, J., Dinauer, M. C. & Ye, R. D. A critical role of protein kinase C delta activation loop phosphorylation in formyl-methionyl-leucyl-phenylalanine-induced phosphorylation of p47(phox) and rapid activation of nicotinamide adenine dinucleotide phosphate oxidase. J. Immunol. 179, 7720\u20137728 (2007).","journal-title":"J. Immunol."},{"key":"23409_CR51","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/978-1-0716-0154-9_12","volume":"2087","author":"NJ Magon","year":"2020","unstructured":"Magon, N. J., Parker, H. A., Ashby, L. V., Springer, R. J. & Hampton, M. B. Analysis of neutrophil bactericidal activity. Methods Mol. Biol. 2087, 149\u2013164 (2020).","journal-title":"Methods Mol. Biol."},{"key":"23409_CR52","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1182\/blood-2017-05-785253","volume":"132","author":"A Pang","year":"2018","unstructured":"Pang, A. et al. Shear-induced integrin signaling in platelet phosphatidylserine exposure, microvesicle release, and coagulation. Blood 132, 533\u2013543 (2018).","journal-title":"Blood"},{"key":"23409_CR53","doi-asserted-by":"crossref","unstructured":"Cuenca, A. G., Delano, M. J., Kelly-Scumpia, K. M., Moldawer, L. L. & Efron, P. A. Cecal ligation and puncture. Curr. Protoc. Immunol. Chapter 19, Unit 19 13 (2010).","DOI":"10.1002\/0471142735.im1913s91"},{"key":"23409_CR54","doi-asserted-by":"crossref","unstructured":"Cheng, N., Liang, Y., Du, X. & Ye, R. D. Serum amyloid A promotes LPS clearance and suppresses LPS-induced inflammation and tissue injury. EMBO Rep. 19, e45517 (2018).","DOI":"10.15252\/embr.201745517"},{"key":"23409_CR55","doi-asserted-by":"publisher","first-page":"227","DOI":"10.2144\/btn-2018-0017","volume":"65","author":"AM Park","year":"2018","unstructured":"Park, A. M. & Tsunoda, I. Forensic luminol reaction for detecting fecal occult blood in experimental mice. Biotechniques 65, 227\u2013230 (2018).","journal-title":"Biotechniques"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-23409-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-23409-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-23409-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T12:44:55Z","timestamp":1669985095000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-23409-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,27]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["23409"],"URL":"https:\/\/doi.org\/10.1038\/s41467-021-23409-0","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,27]]},"assertion":[{"value":"23 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Patents related to this study: U.S. Provisional Application No. 62\/932,024 (University of Illinois), X.D. has ownership interests in DMT Inc., which licenses the university patents. R.A.S. is employed by DMT Inc. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3185"}}